Abstract | BACKGROUND: The aim of this study was to determine the role of hepatitis B virus (HBV) vaccination as defined by the seroconversion to hepatitis B surface antibody (anti-HBs) positivity in peripheral blood stem cell transplants. METHODS: A total of 65 recipients and their donors were enrolled in this study. Recipients were divided into four distinct groups. Group 1 consisted of individuals who were vaccinated, group 2 consisted of individuals who were naturally immunized, group 3 consisted of individuals who were HBs-Ag positive, and group 4 consisted of individuals who were HBV naïve and not vaccinated. RESULTS: Eighty-eight percent of the HBV-vaccinated recipients (14 of 16), who had vaccinated-donors, seroconverted to anti-HBs positivity. Eighty-three percent of HBV-naïve recipients (five of six), who received stem cells from HBV-immune donors, seroconverted to anti-HBs positivity. Two of the four HBs-Ag positive recipients with HBV-immune donors seroconverted to anti-HBs positivity after transplantation. Fifty-seven percent of previously vaccinated-recipients (eight of 14) lost detectable anti-HBs antibody following transplantation. Finally, 31% of HBV-naïve recipients with HBV-naïve donors acquired a de novo HBV infection. CONCLUSIONS: (i) Hepatitis B virus immunization of recipients of allogeneic hematopoietic cell transplantation results in an effective antibody response. (ii) The HBV-immune status of the donor plays an important role in post-transplantation HBs-Ab on seroconversion. (iii) Systematic re-immunization of recipients will be necessary to maintain HBV immunity in long-term serving recipients.
|
Authors | Ramazan Idilman, Celalettin Ustün, Selim Karayalçin, Aslihan Aktemel, Ahmet R Turkyilmaz, Muhit Ozcan, Onder Arslan, A Mithat Bozdayi, David H Van Thiel, Hamdi Akan |
Journal | Clinical transplantation
(Clin Transplant)
Vol. 17
Issue 5
Pg. 438-43
(Oct 2003)
ISSN: 0902-0063 [Print] Denmark |
PMID | 14703927
(Publication Type: Journal Article)
|
Chemical References |
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
|
Topics |
- Adolescent
- Adult
- Female
- Hepatitis B
(immunology, prevention & control)
- Hepatitis B Antibodies
(blood)
- Hepatitis B Surface Antigens
(blood)
- Humans
- Immunity, Innate
- Male
- Middle Aged
- Peripheral Blood Stem Cell Transplantation
- Preoperative Care
- Tissue Donors
- Vaccination
|